Cargando…
Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women
BACKGROUND: In adults with febrile urinary tract infection (fUTI), data on optimal treatment duration in patients other than non-pregnant women without comorbidities are lacking. METHODS: A randomized placebo-controlled, double-blind, non-inferiority trial among 35 primary care centers and 7 emergen...
Autores principales: | van Nieuwkoop, Cees, van der Starre, Willize E., Stalenhoef, Janneke E., van Aartrijk, Anna M., van der Reijden, Tanny J. K., Vollaard, Albert M., Delfos, Nathalie M., van ’t Wout, Jan W., Blom, Jeanet W., Spelt, Ida C., Leyten, Eliane M. S., Koster, Ted, Ablij, Hans C., van der Beek, Martha T., Knol, Mirjam J., van Dissel, Jaap T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376681/ https://www.ncbi.nlm.nih.gov/pubmed/28366170 http://dx.doi.org/10.1186/s12916-017-0835-3 |
Ejemplares similares
-
Diabetes and the Course of Febrile Urinary Tract Infection
por: van der Starre, Willize E., et al.
Publicado: (2013) -
Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule
por: Stalenhoef, Janneke E., et al.
Publicado: (2017) -
Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection
por: Stalenhoef, Janneke Evelyne, et al.
Publicado: (2019) -
Treatment Duration of Febrile Urinary Tract Infections
por: van der Starre, Willize E., et al.
Publicado: (2011) -
Urinary Proteins, Vitamin D and Genetic Polymorphisms as Risk Factors for Febrile Urinary Tract Infection and Relation with Bacteremia: A Case Control Study
por: van der Starre, Willize E., et al.
Publicado: (2015)